N. Ayotte

Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia

C. Labrie, F. Labrie, C. Martel, 2011, Climacteric : the journal of the International Menopause Society.

Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy

C. Labrie, F. Labrie, C. Martel, 2009, Menopause.

Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women.

C. Labrie, F. Labrie, C. Martel, 2014, The journal of sexual medicine.

Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study

L. Derogatis, F. Labrie, C. Martel, 2016, Hormone molecular biology and clinical investigation.

Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration

C. Labrie, R. Bérubé, F. Labrie, 2009, Menopause.

Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women

C. Labrie, F. Labrie, C. Martel, 2009, Menopause.

Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women

F. Labrie, C. Martel, D. Archer, 2015, Menopause.

Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study.

C. Labrie, F. Labrie, C. Martel, 2015, Maturitas.

Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20.

A. Fisher, C. Bouchard, G. Shangold, 2001, Contraception.

Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophy

C. Labrie, F. Labrie, C. Martel, 2015, Climacteric : the journal of the International Menopause Society.

High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy

C. Labrie, F. Labrie, C. Martel, 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Clinical assessment and quality of life of postmenopausal women treated with a new intermittent progestogen combination hormone replacement therapy: a placebo-controlled study

M. Gelfand, J. Hilditch, C. Lau, 2003, Menopause.